Literature DB >> 31970778

Anti-inflammatory effect of octyl gallate in alveolar macrophages cells and mice with acute lung injury.

Gabriela Viegas Haute1, Carolina Luft1,2, Géssica Luana Antunes2, Josiane Silva Silveira2, Bruno de Souza Basso1, Mariana Severo da Costa2, Vitor Giancarlo Schneider Levorse1, Daniela Benvenutti Kaiber2, Márcio Vinícius Fagundes Donadio2, Jordi Gracia-Sancho3,4, Jarbas Rodrigues de Oliveira1.   

Abstract

Acute lung injury (ALI) is an inflammatory process, and has high incidence and mortality. ALI and the acute respiratory distress syndrome are two common complications worldwide that result in acute lung failure, sepsis, and death. Pro-inflammatory substances, such as cytokines and chemokines, are responsible for activating the body's defense mechanisms and usually mediate inflammatory processes. Therefore, the research of substances that decrease the uncontrolled response of organism is seen as potential for patients with ALI. Octyl gallate (OG) is a phenolic compound with therapeutic actions namely antimicrobial, antiviral, and antifungal. In this study, we evaluated its action on lipopolysaccharide (LPS)-activated alveolar macrophages RAW 264.7 cells and ALI in male mice. Our results demonstrated protective effects of OG in alveolar macrophages activated with LPS and mice with ALI. The OG treatment significantly decreased the inflammatory markers in both studies in vitro and in vivo. The data suggested that OG can act as an anti-inflammatory agent for ALI.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute lung injury; inflammation; macrophages; octyl gallate

Year:  2020        PMID: 31970778     DOI: 10.1002/jcp.29536

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

Review 1.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

2.  Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation.

Authors:  Cai Zhang; Xinran Wang; Chunguo Wang; Cheng He; Quantao Ma; Jialin Li; Weiling Wang; Yan-Tong Xu; Ting Wang
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

3.  Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms.

Authors:  Rongjia Zhu; Tingdong Yan; Yingmei Feng; Yan Liu; Hongcui Cao; Gongxin Peng; Yanlei Yang; Zhen Xu; Jingqi Liu; Wei Hou; Xiaoyue Wang; Zhe Li; Luchan Deng; Shihua Wang; Jing Li; Qin Han; Hongling Li; Guangliang Shan; Yinghao Cao; Xingyan An; Jianshe Yan; Zhonghui Zhang; Huafei Li; Xuebin Qu; Jiaqi Zhu; Shumin Zhou; Jiao Wang; Fengchun Zhang; Jinming Gao; Ronghua Jin; Dayong Xu; Yan-Qing Ma; Tao Huang; Shuang Peng; Zhi Zheng; Ilia Stambler; Eric Gilson; Lee Wei Lim; Alexey Moskalev; Antonio Cano; Sasanka Chakrabarti; Brun Ulfhake; Huanxing Su; Haoying Xu; Sihuan Xu; Feng Wei; Holly M Brown-Borg; Kyung-Jin Min; Georgina Ellison-Hughes; Calogero Caruso; Kunlin Jin; Robert Chunhua Zhao
Journal:  Cell Res       Date:  2021-10-26       Impact factor: 25.617

4.  Mir-204 Regulates LPS-Induced A549 Cell Damage by Targeting FOXK2.

Authors:  Shufen Li; Lifen Zhao; Xujiong Li; Gaiping Shang; Lijing Gao; Zhuohui Song; Ting Li
Journal:  J Healthc Eng       Date:  2021-11-30       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.